About Biosign Technologies - Profile
- Biosign Technologies » management
- Biomedical company » factsheet
- Based in Toronto, Ontario » map
- Stock Exchange » CNSX:BIO
General Information
- Corporation Name
- Biosign Technologies Inc.
- Mail Address
- 175 Commerce Valley Drive West, Suite 230, Thornhill, ON, L3T 7P6
- Contact Person
- Lorraine Grouios
- Telephone
- +1 416-218-9800 ext. 225
- Facsimile
- +1 905-886-8996
- office@biosign.com
- Website
- http://www.biosign.com
Corporate Data
- Jurisdiction
- Ontario, Canada
- Formation Date
- 2006 July 14
- Corporation Number
- 1705282
- Business Number
- 86101 4546 RC0001
- CUSIP Number
- 09070P
- Fiscal Year-End
- December 31
- Auditor
- Collins Barrow LLP
Stock Market
- Exchange
- Canadian National Stock Exchange (CNSX)
- Symbol
- BIO
- Listing Date
- 2006-08-21
- Common Shares
- 69,346,782 (December 2009)
- Transfer Agent
- Computershare Trust Company of Canada
Industry Codes (NAICS)
- 51121
- Software Publishers
- 33451
- Measuring, Medical and Controlling Devices
- 33911
- Medical Instrument Manufacturing
Certifications
- Quality Management
- ISO 9001:2000 (organization)
- Quality Management
- ISO 13485 (medical devices)
- Quality Advisor
- Orion Canada
- Quality Auditor
- SGS
Registered Trademarks
- UFIT®
- Canada, USA, EU
Goods & Services Market
- Technology
- Medical Devices - meters, monitors, mentors
- Information
- Health Informatics - processors, recorders, reporters
- Services
- Health Care - evaluation & management
Directors
- Tony LaVista
- Royal Bank (retired)
- Radu Leca
- Biosign Technologies Inc.
- Mouane Sengsavang
- Buttonwood Law Corporation
- David Silver - Chairman
- Johns Hopkins Applied Physics Laboratory
Officers
- Radu Leca
- Chief Executive Officer
- Peter Tassiopoulos
- Chief Operating Officer
- Christian Sleight
- Chief Technology Officer